| CANDRIAM EQUITIES L BIOTECHNOLOGY C CAP USD | RVI BIOTECNOLOGÍA | 51,77% | 47,87% | 69,78% | 160,47% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY V CAP USD | RVI BIOTECNOLOGÍA | 51,77% | 49,99% | 71,95% | 171,61% |
| ROBECO QI EMERGING MARKETS ACTIVE EQUITIES I EUR | RVI EMERGENTES | 51,76% | 101,77% | 96,25% | 254,98% |
| BGF EMERGING MARKETS X2 EUR | RVI EMERGENTES | 51,74% | 60,42% | 26,96% | · |
| UBS (LUX) EQUITY SICAV - GLOBAL EMERGING MARKETS OPPORTUNITY (USD) (CHF HEDGED) Q-DIST | RVI EMERGENTES CRECIMIENTO | 51,73% | 70,19% | 17,04% | · |
| MAN JAPAN COREALPHA EQUITY D H CHF | RVI JAPÓN | 51,72% | 119,35% | · | 326,05% |
| AMUNDI FUNDS ASIA EQUITY FOCUS F2 USD (C) | RVI ASIA EX-JAPÓN | 51,71% | 75,73% | 36,86% | 116,94% |
| ABRDN SICAV I-EMERGING MARKETS SDG EQUITY FUND X ACC USD | RVI EMERGENTES | 51,69% | 66,09% | 44,32% | · |
| ALLIANZ TOTAL RETURN ASIAN EQUITY A USD | RVI ASIA EX-JAPÓN | 51,69% | 63,92% | 21,54% | 141,64% |
| GAM MULTISTOCK JAPAN SPECIAL SITUATIONS C EUR HEDGED | RENT. ABSOLUTA. | 51,69% | 74,30% | 91,50% | 198,96% |
| FTGF CLEARBRIDGE EMERGING MARKETS X USD CAP | RVI EMERGENTES | 51,68% | 63,87% | 30,80% | · |
| MAN JAPAN COREALPHA EQUITY D H USD | RVI JAPÓN | 51,68% | 116,42% | · | 358,36% |
| MAN JAPAN COREALPHA EQUITY I H GBP | RVI JAPÓN | 51,67% | 137,43% | · | 304,83% |
| VONTOBEL FUND-MTX EMERGING MARKETS LEADERS G USD CAP | RVI EMERGENTES | 51,67% | 81,65% | 44,77% | · |
| CT (LUX) ASIAN EQUITY INCOME AE EUR | RVI ASIA EX-JAPÓN | 51,66% | 68,00% | 48,71% | 179,73% |
| GAM MULTISTOCK JAPAN SPECIAL SITUATIONS R EUR HEDGED | RENT. ABSOLUTA. | 51,66% | 74,28% | 91,46% | 199,03% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY I-H CAP EUR | RVI BIOTECNOLOGÍA | 51,63% | 50,80% | 43,84% | 124,21% |
| BGF SUSTAINABLE ENERGY E2 USD | RVI ENERGÍA | 51,62% | 39,06% | 52,19% | 198,04% |
| ROBECO QI EMERGING MARKETS ACTIVE EQUITIES F EUR | RVI EMERGENTES | 51,62% | 101,25% | 95,50% | 253,51% |
| SCHRODER ISF CHINA A I ACC USD | RVI CHINA | 51,62% | 38,89% | 7,74% | · |
